Neuroscience

Smaller hippocampus linked to cognitive decline

With the rise of new drugs that can target the amyloid-beta plaques in the brain that are an early sign of Alzheimer's disease, new ways are needed to determine whether memory loss and thinking problems are due to Alzheimer's ...

Neuroscience

COVID-19 brain fog and the role of Tau proteins

A study published in PNAS Nexus identifies a molecule that may be behind cognitive symptoms, including "brain fog," experienced by those infected by the SARS-CoV-2 virus.

Alzheimer's disease & dementia

New blood test gives high accuracy screen for Alzheimer's disease

A new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest ...

page 2 from 40